40
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Successful Treatment of Aggressive HIV-associated Non-Hodgkin's Lymphoma with Combination Chemotherapy, Biotherapy with Rituximab and HAART: Presentation of a Therapeutic Option

, , , , , & show all
Pages 349-351 | Published online: 01 Jul 2009

  • DeMario, M.D. and Leibovitz, D.N. (1998) "Lymphomas in the immunocompromized patient", Semin. Oncol. 25, 492-502.
  • Levine, A.M., Seneviratne, L., Aspina, B.M., Wohl, A.R., Tulpule, A., Nathwani, B.N. and Gill, P.S. (2000) "Evolving characteristics of AIDS-related lymphoma", Blood 96, 4084-4090.
  • Grillo-Lopez, A.J. (2000) "Rituximab: an insider's historical perspective", Semin. Oncol. 27(Suppl. 12), 9-16.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., and Gisselbrecht, C. (2002) "CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma", N. Engl. J. Med. 346(4), 235-242.
  • Milpied, N., Vasseur, B., Parquet, N., Garnier, J.L., Antoine, C., Quartier, A.S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A.M., Hurault de Ligny, B., Dubief, F., Mathieu-Boue, A. and Leblond, V. (2000) "Humanized anti-CD20 monoclonal antibody (Rituximab) in transplant B-lymphoproliferative disorder: a retrospective study on 32 patients", Ann. Oncol. 11, 113-116.
  • Treon, S.P., Agus, D.B., Link, B., Rodrigues, G., Molina, A., Lacy, M.Q., Emmanouilides, C., Richards, A.I., Clark, B., Lucas, M.S., Schlossman, R., Schenkein, D., Lin, B., Kimby, E., Anderson, K.C. and Byrd, J.C. (2001) "CD20-directed antibody-mediated immunotherapy induced resoponses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia", J. Immunother. 24, 272-279.
  • Shvidel, L., Klepfish, A. and Berrebi, A. (2001) "Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma", Am. J. Hematol. 67, 213-214.
  • Cohen, Y., Polliack, A., Zelig, O. and Goldfarb, A. (2001) "Monotherapy with Rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma", Leuk. Lymphoma 42, 1405-1408.
  • Wilson, W.H. (2000) "Chemotherapy sensitization by Rituximab: experimental and clinical evidence", Semin. Oncol. 27(Suppl. 12), 30-36.
  • Sweetenham, J., Hieke, K., Kerrigan, M., Howard, P., Smartt, P.F., McIntosh, G. and Townshend, S. (1999) "Cost-minimization analysis of CHOP, fludarabine and Rituximab in the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.", Br. J. Haematol. 106, 47-54.
  • Perez, C.L. and Rudoy, S. (2001) "Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient", Clin. Diagn. Lab. Immunol. 8. 993-996.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.